XML 22 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
4. Revenue Recognition
3 Months Ended
Mar. 31, 2018
Revenue Recognition [Abstract]  
Revenue Recognition

Our products consist of the following:

 

Antimony: includes antimony oxide, sodium antimonate, and antimony metal

 

Zeolite: includes course and fine zeolite crushed in various sizes.

 

Precious Metals: includes refined gold and silver

 

For our antimony and zeolite products, revenue is recognized upon the completion of the performance obligation which is met when the transaction price can be reasonably estimated and revenue is recognized generally at the time when risk is transferred. We have determined the performance obligation is met and title is transferred either upon shipment from our warehouse locations or upon receipt by the customer as specified in individual sales orders. The performance obligation is met because at that time, 1) legal title is transferred to the customer, 2) the customer has accepted the product and obtained the ability to realize all of the benefits from the product, 3) the customer has the significant risks and rewards of ownership to it, 4) it is very unlikely product will be rejected by the customer upon physical receipt, and 5) we have the right to payment for the product. Shipping costs related to the sales of antimony and zeolite products are recorded to cost of sales as incurred. For zeolite products, royalty expense due a third party by the Company is also recorded to cost of sales upon sale in accordance with terms of underlying royalty agreements.

  

For sales of precious metals, the performance obligation is met, the transaction price is known, and revenue is recognized at the time of transfer of control of the agreed-upon metal quantities to the customer. Refining and shipping costs related to sales of precious metals are recorded to cost of sales as incurred.

 

Sales of products for the thee-month periods ended March 31, 2018 and 2017 were as follows:

 

    Three Months Ended  
    March 31,  
    2018     2017  
Antimony   $ 1,681,812     $ 1,986,507  
Zeolite     690,707       612,012  
Precious metals     60,410       20,811  
    $ 2,432,929     $ 2,619,330  

 

The following is sales information by geographic area based on the location of customers for the three-month periods ended March 31, 2018 and 2017:

 

 

    Three Months Ended  
    March 31,  
    2018     2017  
United States   $ 2,099,521     $ 2,297,055  
Canada     185,238       322,275  
Mexico     148,170       -  
    $ 2,432,929     $ 2,619,330  

 

Sales of products to significant customers were as follows for the three-month periods ended March 31, 2018 and 2017:

 

Sales to Three    For the Period Ended  
Largest Customers  

March 31,

2018

   

March 31,

2017

 
Kohler Corporation   $ 316,772     $ 445,178  
Ampacet Corporation     184,142       -  
East Penn Manufacturing     -       148,643  
Mexichem Speciality Compounds     728,578       786,425  
    $ 1,229,492     $ 1,380,246  
% of Total Revenues     50.50 %     52.70 %

 

Three Largest            
Accounts Receivable  

March 31,

2018

   

March 31,

2017

 
Kohler Corporation         $ 149,124  
Axens North America Inc.   $ 38,404       -  
Mexichem Speciality Compounds     148,170       135,680  
Teck America     59,110       -  
Nutreco Canada Inc.     -       28,139  
    $ 245,684     $ 312,943  
% of Total Receivables     59.50 %     56.50 %

  

Our trade accounts receivable balance related to contracts with customers was $412,546 at March 31, 2018 and $362,579 at December 31, 2017. Our products do not involve any warranty agreements and product returns are not typical.

 

We have determined our contracts do not include a significant financing component. For antimony and zeolite sales contracts, we may factor certain receivables and receive final payment within 30 days of the performance obligation being met. For antimony and zeolite receivables not factored, we typically receive payment within 10 days. For precious metals sales, a provisional payment of 75% is typically received within 45 days of the date the product is delivered to the customer. After an exchange of assays, a final payment is normally received within 90 days of product delivery.

 

We do not incur significant costs to obtain contracts, or costs to fulfill contracts which are not addressed by other standards. Therefore, we have not recognized an asset for such costs as of March 31, 2018 or December 31, 2017.